1. Home
  2. FPI vs EYPT Comparison

FPI vs EYPT Comparison

Compare FPI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

N/A

Current Price

$11.09

Market Cap

541.2M

Sector

Real Estate

ML Signal

N/A

EYPT

EyePoint Pharmaceuticals Inc.

N/A

Current Price

$12.73

Market Cap

1.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
FPI
EYPT
Founded
2013
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
541.2M
1.5B
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
FPI
EYPT
Price
$11.09
$12.73
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
N/A
$31.80
AVG Volume (30 Days)
577.7K
1.2M
Earning Date
05-06-2026
03-04-2026
Dividend Yield
3.32%
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$52,178,000.00
$7,539,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,031.72
P/E Ratio
$17.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$3.91
52 Week High
$13.23
$19.11

Technical Indicators

Market Signals
Indicator
FPI
EYPT
Relative Strength Index (RSI) 37.40 36.03
Support Level $10.49 $11.88
Resistance Level $11.15 $13.32
Average True Range (ATR) 0.36 0.97
MACD -0.21 -0.32
Stochastic Oscillator 14.35 11.68

Price Performance

Historical Comparison
FPI
EYPT

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: